Citations

Showing 10 of 108104 citations.

Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease
Shiffman, Mitchell L. , Freilich, B., Watt, Kymberly D. , Chan, Jean L., Spada, Al, Hagerty, David , Schiff, Eugene R. , Watt, Kymberly, Hagerty, David T , Vuppalanchi, Raj , Chan, Jean L.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | November 15, 2018 | Volume: 49 | Issue: 1 | Pages: 64-73

10.1111/apt.15030 | PMID 30430605 Get It

SummaryBackgroundLipotoxicity leading to excessive caspase‐mediated apoptosis and inflammation is believed to drive liver damage in NAFLD. Emricasan is a pan‐caspase inhibitor that decreased serum ALT and apoptotic and inflammatory markers in subjects with chronic hepatitis.AimsTo assess whether 28 days of emricasan would reduce elevated levels of serum ALT, AST, cleaved cytokeratin‐18, full‐length cytokeratin‐18, and caspase 3/7 in subjects with NAFLD and raised aminotransferases.MethodsDouble‐blind, placebo‐controlled, office‐practice study assessed the efficacy, safety, and tolerability of emricasan in subjects with NAFLD and ALT levels ≥1.5 x ULN during screening. Subjects were randomised to emricasan 25 mg twice daily or matching placebo. Subjects with cirrhosis and other causes for raised aminotransferases were excluded. The primary endpoint was the change in ALT at day 28 in the emricasan group vs placebo.Results38 subjects were randomised, 19 each to emricasan or placebo. Baseline disease factors were well balanced except for lower median ALT values in emricasan subjects. Three subjects randomised to placebo discontinued prior to day 28. ALT values decreased significantly in emricasan‐treated subjects vs placebo at days 7 (P < 0.0001) and 28 (P = 0.02). cCK18 (day 7), flCK18 (days 7 and 28), and caspase 3/7 (day 7) were also significantly decreased in emricasan‐treated subjects vs placebo. Emricasan treatment was generally safe and well tolerated.ConclusionsEmricasan decreased ALT and biomarkers in subjects with NAFLD and raised aminotransferases after 28 days. These results support the further development of emricasan in patients with NAFLD. Trial registration: ClinicalTrials.gov, Identifier: NCT02077374.
Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic Paralysis
Calvert, Jonathan S. , Grahn, Peter J. , Strommen, Jeffrey A., Lavrov, Igor , Gill, Megan L., Linde, Margaux B. , Straaten, Meegan G. Van , Veith, Daniel D. , Lopez, Cesar , Sayenko, Dimitry G. , Gerasimenko, Yury , Edgerton, V. Reggie , Zhao, Kristin D. , Lee, Kendall H. , Lavrov, Igor A, Brown, Desmond A., Van Straaten, Meegan G, Lavrov, Igor , Trentadue, Taylor P , Beck, Lisa A., Brown, Desmond , Sayenko, Dimitry G

Mayo Clinic

Journal of Neurotrauma | November 15, 2018 | Volume: 36 | Issue: 9 | Pages: 1451-1460

10.1089/neu.2018.5921 | PMID 30430902 Get It

Epidural electrical stimulation (EES) of the spinal cord has been shown to restore function after spinal cord injury (SCI). Characterization of EES-evoked motor responses has provided a basic understanding of spinal sensorimotor network activity related to EES-enabled motor activity of the lower extremities. However, the use of EES-evoked motor responses to guide EES system implantation over the spinal cord and their relation to post-operative EES-enabled function in humans with chronic paralysis attributed to SCI has yet to be described. Herein, we describe the surgical and intraoperative electrophysiological approach used, followed by initial EES-enabled results observed in 2 human subjects with motor complete paralysis who were enrolled in a clinical trial investigating the use of EES to enable motor functions after SCI. The 16-contact electrode array was initially positioned under fluoroscopic guidance. Then, EES-evoked motor responses were recorded from select leg muscles and displayed in real time to determine electrode array proximity to spinal cord regions associated with motor activity of the lower extremities. Acceptable array positioning was determined based on achievement of selective proximal or distal leg muscle activity, as well as bilateral muscle activation. Motor response latencies were not significantly different between intraoperative recordings and post-operative recordings, indicating that array positioning remained stable. Additionally, EES enabled intentional control of step-like activity in both subjects within the first 5 days of testing. These results suggest that the use of EES-evoked motor responses may guide intraoperative positioning of epidural electrodes to target spinal cord circuitry to enable motor functions after SCI.
MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management
Khan, Aliya , Rejnmark, Lars , Brandi, Maria Luisa , Clarke, Bart, Brandi, Maria Luisa , Rejnmark, Lars , Clarke, B.L.

Mayo Clinic

European Journal of Endocrinology | November 15, 2018 | Volume: 180 | Issue: 2 | Pages: R37-R44

10.1530/eje-18-0541 | PMID 30444723 Get It

Purpose Review calcium homeostasis in pregnancy and provide evidence-based best practice recommendations for the management of hypoparathyroidism in pregnancy. Methods We searched MEDLINE, EMBASE and Cochrane databases from January 2000 to April 1, 2018. A total of 65 articles were included in the final review. Conclusions During pregnancy, calcitriol levels increase by two- to—three-fold resulting in enhanced intestinal calcium absorption. The renal filtered calcium load increases leading to hypercalciuria. PTHrP production by the placenta and breasts increases by three-fold, and this may lower the doses of calcium and calcitriol required during pregnancy in mothers with hypoparathyroidism. The literature however describes a wide variation in the required doses of calcium and calcitriol during pregnancy in hypoparathyroid mothers, with some women requiring higher doses of calcitriol, whereas others require lower doses. Close monitoring is necessary as hypercalcemia in the mother may suppress the fetal parathyroid gland development. Also hypocalcemia in the mother is harmful as it may result in secondary hyperparathyroidism in the fetus. This may be associated with demineralization of the fetal skeleton and the development of intrauterine fractures. Inadequate treatment of hypoparathyroidism may also result in uterine contractions and an increased risk of miscarriage. Treatment targets during pregnancy are to maintain a low normal serum calcium. Calcium, calcitriol and vitamin D supplements are safe during pregnancy. Close monitoring of the mother with a multidisciplinary team is advised for optimal care. If calcium homeostasis is well controlled during pregnancy, most women with hypoparathyroidism have an uncomplicated pregnancy and give birth to healthy babies.
From the Masters: Lumper? Or splitter?
Rooke, Thom W. , Rooke, Thom

Mayo Clinic

Vascular Medicine | November 15, 2018 | Volume: 24 | Issue: 1 | Pages: 3-5

10.1177/1358863x18808903 | PMID 30428783 Get It

Robotic extralevator excision of a retrorectal giant aggressive angiomyxoma
Kelley, Scott R. , Kelley, Scott R

Mayo Clinic

Obstetrics & Gynecology Science | November 15, 2018 | Volume: 61 | Issue: 6 | Pages: 693

10.5468/ogs.2018.61.6.693 | PMID 30474017 Get It

Acute ischemic stroke secondary to cardiac embolus of a ‘foreign body’ material after a redo sternotomy for mitral valve replacement: A case report
Fitzgerald, Seán , Rizvi, Asim , Williamson, Eric E. , Doyle, Karen , Kallmes, David F. , Brinjikji, Waleed , Dai, Daying , Fitzgerald, Seán , Lanzino, Giuseppe

Mayo Clinic

Interventional Neuroradiology | November 14, 2018 | Volume: 25 | Issue: 2 | Pages: 208-211

10.1177/1591019918810538 | PMID 30428742 Get It

Summary Cardiac surgery has been shown to be associated with increased risk of acute ischemic stroke. This report presents a case of a successful mechanical embolectomy procedure to treat a patient for an acute ischemic stroke, which was caused by the cardiac embolization of a ‘foreign body’ containing debris following a redo sternotomy procedure for mitral valve replacement and tricuspid valve annuloplasty.
CSF1R -related leukoencephalopathy
Kasanuki, Koji , Wszołek, Zbigniew K. , Konno, Takuya , Wszolek, Z.K. , Ikeuchi, Takeshi , Dickson, Dennis W.

Mayo Clinic

Neurology | November 14, 2018 | Volume: 91 | Issue: 24 | Pages: 1092-1104

10.1212/wnl.0000000000006642 | PMID 30429277 Get It

Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicenter, Controlled Study in a Naturalistic Setting
Nides, Mitchell, Danielsson, Tobias , Saunders, Frederick, Perfekt, Roland, Kapikian, Roxanne, Solla, Janice, Leischow, Scott J. , Myers, Andrew , Saunders, Frederick

Mayo Clinic

Nicotine & Tobacco Research | November 14, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ntr/nty246 | PMID 30452732 Get It

Venetoclax for the treatment of multiple myeloma
Sidiqi, M Hasib , Gertz, Morie A. , Vaxman, Iuliana , Sidiqi, M Hasib , Gertz, Morie A , Vaxman, Iuliana

Mayo Clinic

Expert Review of Hematology | November 14, 2018 | Volume: 11 | Issue: 12 | Pages: 915-920

10.1080/17474086.2018.1548931 | PMID 30428277 Get It

Arousal-Based Scoring for Obstructive Sleep Apnea
Malhotra, Raman K. , Kirsch, Douglas B. , Carden, Kelly A., Rosen, Ilene M. , Ramar, Kannan

Mayo Clinic

Journal of Clinical Sleep Medicine | November 14, 2018 | Volume: 14 | Issue: 11 | Pages: 1963-1964

10.5664/jcsm.7508 | PMID 30373700 Get It